Aehr Test Systems $AEHR is Pier Capital LLC’s 3rd Largest Position

Pier Capital LLC decreased its stake in Aehr Test Systems (NASDAQ:AEHR) by 8.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 370,955 shares of the semiconductor company’s stock after selling 34,977 shares during the period. Aehr Test Systems comprises about 1.7% of Pier Capital LLC’s investment portfolio, making the stock its 3rd biggest position. Pier Capital LLC owned 1.24% of Aehr Test Systems worth $11,169,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Jones Financial Companies Lllp grew its position in Aehr Test Systems by 3,448.3% in the third quarter. Jones Financial Companies Lllp now owns 1,029 shares of the semiconductor company’s stock worth $31,000 after acquiring an additional 1,000 shares in the last quarter. RiverPark Advisors LLC purchased a new stake in Aehr Test Systems during the third quarter valued at about $42,000. State of Wyoming purchased a new stake in Aehr Test Systems during the second quarter valued at about $28,000. Russell Investments Group Ltd. lifted its stake in Aehr Test Systems by 3,500.0% during the third quarter. Russell Investments Group Ltd. now owns 2,448 shares of the semiconductor company’s stock worth $74,000 after purchasing an additional 2,380 shares during the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in Aehr Test Systems by 99.5% during the third quarter. BNP Paribas Financial Markets now owns 5,533 shares of the semiconductor company’s stock worth $167,000 after purchasing an additional 2,759 shares during the last quarter. 69.69% of the stock is owned by institutional investors.

Aehr Test Systems Trading Down 11.3%

AEHR opened at $37.65 on Friday. Aehr Test Systems has a 12 month low of $6.27 and a 12 month high of $46.95. The business’s 50-day moving average price is $30.81 and its 200-day moving average price is $27.11. The company has a market cap of $1.15 billion, a P/E ratio of -125.50 and a beta of 2.22.

Aehr Test Systems (NASDAQ:AEHR) last issued its earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.04. The company had revenue of $9.88 million during the quarter, compared to analysts’ expectations of $11.45 million. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%. Equities research analysts forecast that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AEHR has been the topic of several recent research reports. Craig Hallum reiterated a “hold” rating on shares of Aehr Test Systems in a research report on Friday, January 9th. Lake Street Capital began coverage on Aehr Test Systems in a research note on Wednesday, December 17th. They issued a “buy” rating for the company. Zacks Research upgraded shares of Aehr Test Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, December 8th. William Blair raised shares of Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research note on Monday, March 2nd. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Aehr Test Systems in a report on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Aehr Test Systems presently has an average rating of “Hold” and an average target price of $21.00.

Insider Buying and Selling

In related news, Director Laura Oliphant sold 4,546 shares of the company’s stock in a transaction on Thursday, January 22nd. The shares were sold at an average price of $31.40, for a total transaction of $142,744.40. Following the completion of the sale, the director directly owned 18,432 shares in the company, valued at $578,764.80. This represents a 19.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Rhea J. Posedel sold 13,998 shares of the stock in a transaction on Friday, February 13th. The shares were sold at an average price of $30.02, for a total transaction of $420,219.96. Following the sale, the director directly owned 456,979 shares of the company’s stock, valued at $13,718,509.58. The trade was a 2.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 6.80% of the company’s stock.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.